Particle Sciences

Barbara Morgan, general manager at Particle Sciences discusses working in the pharma industry and why diversity is so important. Read more


Contract development and manufacturing organisation (CDMO) Particle Sciences has launched a new active pharmaceutical ingredient (API) screening programme in order to strengthen its nanomilling offering. Read more


Drug delivery CDMO Particle Sciences has partnered with Hapten Sciences to progress Hapten’s lead product into the clinic. The product is a vaccine developed to lessen or eliminate contact dermatitis from poison ivy, oak and sumac exposure. Read more


Particle Sciences has teamed up with NETZSCH Premier Technologies to provide drug developers with improved access to state-of-the-art pharmaceutical nanomilling equipment and full pharmaceutical development capabilities. Read more